Health Care Supplies

ULTRAGREEN AI USD

Ultragreen.ai 2025 Fiscal Year Revenue Reaches $114.7 Million, CAGR of 43%

ULTRAGREEN AI USD to Release FY2026 Q1 Earnings on May 5, Pre-Market SGT

UOB Kay Hian and DBS Maintain Buy Ratings for UltraGreen.ai

Ultragreen.ai releases financial report with $142.4 million revenue for fiscal year 2025

ULTRAGREEN AI USD released FY2025 Q3 earnings on February 26, 2026, SGT with actual revenue of USD 0 and actual EPS of USD 0

ULTRAGREEN AI USD released FY2025 9 Months Earnings on February 26, 2026 (SGT), with actual revenue of USD 70.14 M and actual EPS of USD 52.3839

ULTRAGREEN AI USD released FY2025 annual earnings on February 26 After-Market (SGT), actual revenue USD 137.94 M (forecast USD 182.2 M), actual EPS USD 0.19 (forecast USD 0.086)

ULTRAGREEN AI USD released FY2025 Q4 earnings on February 26 After-Market (SGT), with actual revenue USD 0 and actual EPS USD 0

ULTRAGREEN AI USD to Release FY2025 Annual Earnings on February 26, 2026 After-Market (SGT), Forecast Revenue SGD 180.48 M, EPS SGD 0.0852

UltraGreen.ai Limited Receives Regulatory Approvals in Philippines and Malaysia

ULTRAGREEN AI USD released FY2024 Q2 earnings on November 26, 2025 (SGT), with actual revenue of USD 29.15 M and EPS of USD 28.3473

ULTRAGREEN AI USD released FY2023 annual earnings on November 26, 2025, post-market (SGT), with actual revenue of USD 72.03 M and actual EPS of USD 67.4017

ULTRAGREEN AI USD released FY2024 Semi-Annual earnings on November 26, 2025 (SGT), actual revenue USD 58.3 M, actual EPS USD 56.6946

ULTRAGREEN AI USD released FY2022 Annual Earnings on November 26, 2025 (SGT) with actual revenue of USD 49.2 M and actual EPS of USD 48.0336

ULTRAGREEN AI USD released FY2025 Q2 earnings on November 26, 2025 (SGT) with actual revenue of USD 35.07 M and EPS of USD 26.1919

ULTRAGREEN AI USD released FY2024 Q3 earnings on November 26, 2025 SGT with actual revenue of USD 0 and actual EPS of USD 0

ULTRAGREEN AI USD released FY2024 9 Months Earnings on November 26, 2025 (SGT), Actual Revenue: USD 58.3 M, Actual EPS: USD 56.6946

ULTRAGREEN AI USD released FY2024 Annual Earnings on November 26, 2025 (SGT), Actual Revenue: USD 108.02 M, Actual EPS: USD 114.1976

ULTRAGREEN AI USD released FY2024 Q4 earnings on November 26, 2025 (SGT) with actual revenue of USD 0 and EPS of USD 0

ULTRAGREEN AI USD released FY2025 Q1 earnings on November 26, Post-Market (SGT), with actual revenue of USD 35.07 M and EPS of USD 26.1919

SingtelMBeCW260730

Abundance

Geely MB ePW261005

Asiatic

HSI 28000MBePW260629

Alibaba MB eCW260703

Teho

P-Nova Short MSSG-1X USy

NKY 55000MBePW260911

NKY 52000MBePW260612

UltraGreen.ai has invested $12.3m from its IPO proceeds in LifeSignals and IHLD Med Tech to support strategic growth initiatives. The investment includes $5.8m for LifeSignals to enhance biosensor manufacturing and $3.8m for IHLD to expand its platform in India. These transactions are not expected to materially impact FY2026 EPS. UltraGreen.ai retains a balance of $171.8m from its IPO proceeds, aligning with its prospectus intentions.

Singapore Business Review

UltraGreen.ai invests $12.3m in LifeSignals, IHLD

UOB Kay Hian analyst maintained a Buy rating on UltraGreen.ai Limited today and set a price target of $1.95.Claim 55% Off TipRanksUnlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks Currently, the analyst consensus on UltraGreen.ai Limited is a Moderate Buy with an average price target of $1.98.

Tip Ranks

UOB Kay Hian

UltraGreen.ai Limited (ULG) Gets a Buy from UOB Kay Hian

UltraGreen.ai has received regulatory approval in Singapore for Verdye, facilitating its expansion in Southeast Asia. This approval allows access to Singapore's healthcare system, enhancing commercialization efforts and partnerships with local hospitals. Verdye is utilized in fluorescence-guided surgeries across various medical fields. CEO Ravi Sajwan emphasized Singapore's strategic importance in clinical adoption in the region. Verdye is already approved in 41 countries, and the company is also expanding in the Philippines following its recent IPO.

UltraGreen.ai gains Singapore approval for Verdye in regional push

The Singapore Exchange (SGX) aims to enhance sector diversity in initial public offerings (IPOs) to attract more companies, particularly in the AI sector. SGX's head of equities, Ng Yao Loong, emphasized the need for a balanced representation of various industries during an investment conference. He cited UltraGreen.ai's successful IPO as a model. The Monetary Authority of Singapore (MAS) is also working on initiatives to improve market participation and liquidity, with a focus on sustainable growth and long-term value creation amidst geopolitical uncertainties.

Businesstimes News

SGX seeks greater sector diversity in IPOs; aims to attract more AI firms

Singapore's tech unicorn UltraGreen.ai saw its stock rise nearly 30% after going public, but due to poor recent performance and the impact of the Iran war, its share price has been sold off over the past month, nearly giving back all its gains, currently up only 1.3%. The company uses artificial intelligence technology to provide medical imaging solutions, with its main product being the medical dye indocyanine green, which helps doctors improve surgical precision. Analysts are exploring the relationship between its business performance and macroeconomic factors in the market

Zaobao

Unicorn stock UltraGreen.ai's price "returns to its original form" what happened to it? | Lianhe Zaobao

UltraGreen.ai is recommended to buy, with a target price of $1.95 and a closing price of $1.58 (+3.27%). Due to competitor Stryker facing a cyber attack, hospitals may turn to UltraGreen.ai, which is expected to benefit in the short term. The company's IC-Flow imaging system V2 has received approvals from multiple countries, expanding its business to 45 regions, with operating cash of 53 million yuan and initial public offering proceeds reaching $173 million

iShares US Medical Devices

SPDR S&P Health Equip

Stryker

Stock Analysis: Youchuang Kangzhi | Lianhe Zaobao

UOB Kay Hian analyst maintained a Buy rating on UltraGreen.ai Limited today and set a price target of $1.95.Claim 70% Off TipRanks PremiumUnlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential In a report released on March 12, DBS also maintained a Buy rating on the stock with a $2.00 price target.

UOB Kay Hian Keeps Their Buy Rating on UltraGreen.ai Limited (ULG)

Trading in the iEdge Next 50 Index has accelerated, with the average daily turnover rising to $261 million in Q1 2026, up from $221 million in H2 2025. Despite this growth, the Index experienced slight declines. A rebalance on March 23 will add Haw Par Corp, GuocoLand, Ultragreen.ai, and ValueMax Group, while removing Banyan Tree Holdings, SBS Transit, Geo Energy Resources, and COSCO SHIPPING International Singapore Co. The healthcare sector's representation will double, increasing its weighting from 2%-3% to 6%-7%.

ValueMax

GuocoLand

Haw Par

CSOP iEdge SREIT ETF S

Trading in iEdge Next 50 accelerates as ADT hits $261m

ULTRAGREEN AI USD(ULG.SG)